AEON Bio - AEON Net Assets per Single Share

Graphic logo of AEON Biopharma, Inc. (AEON)

Stable production in South Korea according to cGMP standards supports the operational resilience of AEON Biopharma. The historical book value per share chart visualizes this foundation, where the value of -0.58 captures the metric level. Business efficiency is based on outsourcing clinical trials and logistics to partners, while high resistance to macro cycles is ensured by the demand for innovative neurological developments.

AEON Bio (AEON): Share Book Value from 02/21/2024 to 10/27/2026

AEON Biopharma Inc. - analytical breakdowns and key metrics (AEON)

- price and consensus price forecast:
Price Chart AEON Bio|AEON - Average Forecast Price
- market capitalization data:
Market Value AEON Biopharma, Inc.|AEON - Business Value
- book capitalization data:
Net Assets per Single Share AEON Biopharma|AEON - Net Asset Value|Market Capitalization to Book Value Ratio aeonbiopharma.com|AEON - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital AEON Biopharma|AEON - Long-Term Debt to Capital|Short-Term Debt to Equity AEON Bio|AEON - Aggregate Debt Obligations|Debt to Book Capitalization Ratio AEON Biopharma, Inc.
Fundamental company valuation:aeonbiopharma.com - AEON
Manufactured products of AEON Bio

AEON Biopharma maintains resilience through diversified neurotoxin component logistics and long-term laboratory contracts. A BVPS analysis allows for an assessment of net assets per share, where capital stability without write-downs confirms the reliability of the fundamental basis, while growth in this metric signals resource capitalization, which determines the issuer's intrinsic value over the long term.

Competitors of AEON Biopharma (AEON)

JAZZ (Jazz Pharma) - Net Assets per Single Share|CYTK: Net Asset Value per Share|Net Assets per Single Share PTC Therapeutics, Inc.|SRRK (scholarrock.com) - Equity per Share|Net Assets per Single Share Centessa CNTA|Share Book Value Dyne Therapeutics Inc|Edgewise Pharma (EWTX) - Book Value per Share|Accounting Value of a Share Rapport Corp (RAPP)|Book Value per Share ALMS (Alumis Inc.)|zevra.com - Book Value per Share|Net Assets per Single Share Contineum Therapeutics (CTNM)|LRMR: Accounting Value of a Share|CAPR (capricor.com) - Net Assets per Single Share|Entrada Therapeutics, Inc (TRDA) - Accounting Value per Share|PTHS (Channel Therapeutics) - Book Value per Share|Book Value per Share MediciNova Corp (MNOV)|Serina Therapeutics (SER) - Accounting Value per Share|Accounting Value of a Share BTAI (BioXcel Therapeutics Inc)|PMN - Net Assets per Single Share|Equity per Share Apimeds Pharmaceuticals, Inc. APUS|NLSP (NLS Pharma) - Book Value per Share|Bionomics Limited (BNOX) - Net Asset Value per Share|HUGE: Accounting Value per Share|RETA (Reata Pharmaceuticals Inc) - Book Value per Share